NEWS

National Research Delegation Focuses on Advanced Healthcare Manufacturing

Recently, Jiao Hong, Vice Chairperson of the Central Committee of the Chinese Peasants and Workers Democratic Party, Member of the Standing Committee of the Chinese People’s Political Consultative Conference (CPPCC), and former Commissioner of the National Medical Products Administration (NMPA), led a research delegation to Shandong Province to investigate the accelerated development of high-end medical devices in China. During the visit, the delegation conducted an in-depth tour of INTCO Medical, one of the world’s leading healthcare manufacturing enterprises and the global largest manufacturer of non-latex disposable gloves.

Representatives from the Central Committee of the Chinese Peasants and Workers Democratic Party, the Shandong Provincial Committee, the Shandong Medical Products Administration, the Zibo Municipal Government, and local district authorities participated in the research visit. Yu Haisheng, Director and Vice General Manager of INTCO Medical, accompanied the delegation and presented a comprehensive overview of the company’s global development strategy, innovation achievements, and intelligent manufacturing capabilities.

INTCO Medical Strengthens Leadership in High-End Medical Devices

During the visit, the delegation toured multiple production and innovation facilities to better understand the company’s industrial ecosystem across medical consumables, rehabilitation equipment, and physical therapy solutions. The discussions focused on high-end medical device research and development, technology commercialization, intelligent manufacturing, and the future direction of China’s healthcare industry.

As the global largest manufacturer of non-latex disposable gloves, INTCO Medical has established a strong international presence through advanced manufacturing systems and an integrated global supply chain network. The company currently operates large-scale production bases across China and overseas markets, with annual production capacity exceeding 103 billion disposable gloves. Its products are widely supplied to healthcare institutions, laboratories, industrial customers, and emergency response systems worldwide.

Yu Haisheng emphasized that INTCO Medical consistently regards technological innovation as the primary driver of long-term growth. The company continues to increase investment in research and development, accelerate the commercialization of innovative technologies, and improve product quality and operational efficiency through intelligent manufacturing and digital transformation.

In recent years, INTCO Medical has expanded its healthcare portfolio beyond disposable protective products into rehabilitation equipment, physical therapy products, and advanced medical technologies. Through continuous innovation and industrial upgrading, the company has strengthened its international competitiveness while supporting the modernization of the global healthcare supply chain.

Intelligent Manufacturing Supports Global Healthcare Demand

During the discussions, Jiao Hong highly recognized INTCO Medical’s achievements in high-end medical device innovation and smart manufacturing. She noted that China’s medical device industry is entering a critical stage of transformation toward high-end, intelligent, and internationalized development. She emphasized the importance of strengthening enterprise-led innovation, promoting deeper collaboration among industry, universities, and research institutions, and accelerating breakthroughs in key core technologies to improve industrial chain resilience and supply chain security.

The delegation also highlighted the growing importance of intelligent manufacturing in healthcare production. By integrating automation, digital systems, and advanced production technologies, INTCO Medical has built highly efficient manufacturing capabilities capable of responding rapidly to global market demand while maintaining strict international quality standards.

As outlined in INTCO Medical’s corporate development strategy, the company remains committed to technological advancement, sustainable manufacturing, and global market expansion. INTCO Medical currently exports products to more than 150 countries and regions, establishing long-term partnerships with healthcare distributors, hospitals, and medical institutions around the world.

Industry observers note that the company’s vertically integrated supply chain and large-scale manufacturing capacity have positioned it as an important contributor to global healthcare resilience. Its ability to scale production rapidly during periods of increased global demand has further strengthened its reputation within the international healthcare industry.

Continuous Innovation Drives Future Growth

The global healthcare industry continues to experience increasing demand for advanced medical technologies, especially in infection prevention, rehabilitation care, and intelligent healthcare solutions. Against this backdrop, INTCO Medical continues to invest in product innovation, digital manufacturing infrastructure, and global supply chain optimization to meet evolving healthcare needs worldwide.

The company has also strengthened its focus on sustainable manufacturing and operational efficiency through advanced production systems and environmental management initiatives. These efforts align with broader global trends toward responsible healthcare manufacturing and long-term sustainable development.

In addition to expanding production capacity, INTCO Medical continues to enhance its research and innovation ecosystem through collaboration with scientific institutions and healthcare professionals. The company’s integrated innovation platform supports the development of next-generation healthcare solutions while improving clinical application efficiency and patient care outcomes.

The research visit demonstrated growing national support for high-end medical device innovation and reinforced the strategic importance of healthcare manufacturing within China’s industrial development agenda. Experts believe that policy support combined with enterprise-driven innovation will further accelerate the advancement of medical technologies and strengthen China’s position in the global healthcare industry.

INTCO Medical Expands Global Healthcare Presence

Looking ahead, INTCO Medical will continue to deepen its presence in the global healthcare market while accelerating innovation across medical consumables, rehabilitation equipment, and physical therapy solutions. The company plans to further improve intelligent manufacturing capabilities, product quality standards, and global supply chain responsiveness to better serve healthcare providers and consumers worldwide.

As global healthcare systems increasingly prioritize safety, efficiency, and technological innovation, companies with strong research capabilities and scalable manufacturing infrastructure are expected to play an even more important role in the future of healthcare development. INTCO Medical’s continued investment in innovation and international expansion reflects its long-term commitment to supporting global healthcare advancement through reliable and high-quality medical solutions.

The visit not only provided valuable guidance for the future development of China’s high-end medical device industry, but also reinforced INTCO Medical’s strategic direction toward technological innovation, global collaboration, and sustainable healthcare manufacturing. Through continued investment in advanced technologies and intelligent production systems, the company aims to contribute new momentum to the development of the global healthcare industry.

Additional information about global healthcare solutions, disposable glove manufacturing, corporate innovation initiatives, and international business cooperation further demonstrates the company’s commitment to healthcare innovation and worldwide service capabilities. INTCO Medical’s expanding portfolio also includes rehabilitation equipment solutions, physical therapy products, medical manufacturing innovation, sustainability initiatives, and global investor relations.